Skip to main content
. 2022 Sep 22;14(19):4606. doi: 10.3390/cancers14194606

Figure 3.

Figure 3

Overall survival (months) of patients treated with Docetaxel estimated by Kaplan–Meier stratified by Neutrophil to Lymphocyte ratio (NLR) low (≤5) and NLR high (>5) calculated at baseline (a) and at 12 weeks (b).